The use of serum glial fibrillary acidic protein measurements in the diagnosis of neuromyelitis optica spectrum optic neuritis

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Storoni, Mithu ^a,b   Petzold, Axel ^a,c   Plant, Gordon T ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; GLIAL FIBRILLARY ACIDIC PROTEIN;

ADULT; ARTICLE; CHRONIC RELAPSING INFLAMMATORY OPTIC NEUROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID DEPENDENT OPTIC NEUROPATHY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; OPTIC NERVE DISEASE; OPTIC NEURITIS; PROTEIN BLOOD LEVEL; RECURRENT ISOLATED OPTIC NEURITIS; VISUAL ACUITY; BLOOD; METABOLISM; OPTIC NERVE; PATHOLOGY; PATHOPHYSIOLOGY; TIME; VISION;

ADULT; AQUAPORIN 4; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MALE; MULTIPLE SCLEROSIS; NEUROMYELITIS OPTICA; OPTIC NERVE; TIME FACTORS; VISION, OCULAR;

EID: 80051882167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023489     Document Type: Article

References (20)

1. Beck RW, Gal RL, (2008) Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. Arch Ophthalmol 126 (7): 994-5.
2. Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, et al. (2008) NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70 (23): 2197-200.
3. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, et al. (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 11-17;364 (9451): 2106-12.
4. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG, (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6 (9): 805-15.
5. Nakamura M, Nakazawa T, Doi H, Hariya T, Omodaka K, et al. (2010) Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica. Graefes Arch Clin Exp Ophthalmol 248 (12): 1777-85.
6. Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, et al. (2010) IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology 19;75 (16): 1423-7.
7. Kupersmith MJ, Burde RM, Warren FA, Klingele TG, Frohman LP, et al. (1988) Autoimmune optic neuropathy: evaluation and treatment. J Neurol Neurosurg Psychiatry 51 (11): 1381-6 Erratum in: J Neurol Neurosurg Psychiatry 52(5):692.
8. Arndt C, Labauge P, Speeg-Schatz C, Jeanjean L, Fleury M, et al. (2008) [Recurrent inflammatory optic neuropathy]. J Fr Ophtalmol 31 (4): 363-7.
9. Kidd D, Burton B, Plant GT, Graham EM, (2003) Chronic relapsing inflammatory optic neuropathy (CRION). Brain 126 (Pt 2): 276-84.
10. Optic Neuritis Study Group (1991) The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 109 (12): 1673-8.
11. Fujihara K, (2011) Neuromyelitis optica and astrocytic damage in its pathogenesis. J Neurol Sci 2011 Mar 9. [E-publication ahead of print].
12. Takano R, Misu T, Takahashi T, Sato S, Fujihara K, et al. (2010) Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology 20;75 (3): 208-16.
13. Axelsson M, Malmeström C, Nilsson S, Haghighi S, Rosengren L, et al. (2011) Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol 2011 Jan 1. [E-publication ahead of print].
14. Misu T, Takano R, Fujihara K, Takahashi T, Sato S, et al. (2009) Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 80 (5): 575-7.
15. Petzold A, Rejdak K, Plant GT, (2004) Axonal degeneration and inflammation in acute optic neuritis. J Neurol Neurosurg Psychiatry 75 (8): 1178-80.
16. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846.
17. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG, (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66: 1485-1489.
18. Petzold A, Keir G, Green AJ, Giovannoni G, Thompson EJ, (2003) A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 278 (1-2): 179-90.
19. Waters P, Jarius S, Littleton E, Leite MI, Jacob S, et al. (2008) Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 65 (7): 913-9.
20. Burman J, Raininko R, Fagius J, (2010) Bilateral and recurrent optic neuritis in multiple sclerosis. Acta Neurol Scand 123 (3): 207-10.